Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: Germany Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20035
20041
20052
20075
20083
20092
20107
20116
20123
20136
201411
20157
20165
20176
20183
20191
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene12
Novartis Pharmaceuticals8
European Organisation for Research and Treatment of Cancer - EORTC4
Heinrich-Heine University, Duesseldorf3
Kiadis Pharma3
Technische Universität Dresden3
Traws Pharma, Inc.3
AbbVie2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Astex Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes80
Leukemia, Myeloid, Acute35
Leukemia, Myelomonocytic, Chronic15
Anemia8
Leukemia8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Hematologic Neoplasms6
Anemia, Refractory, with Excess of Blasts5
Myeloproliferative Disorders5
Leukemia, Lymphocytic, Chronic, B-Cell4

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.